Contents
Metabolic Myopathies/Storage
Disorders
·
Muscular dystrophies (see Muscular Dystrophies)
o
Duchene, Becker etc.
o
Myotonic dystrophy
Acquired
·
Infectious
Disorders of neuromuscular transmission
·
MG
·
LEMS
·
Botulism
Other DDX for proximal weakness
Pneumonic
HIDE PIE
·
Hereditary
·
Infection (HIV, Toxoplasmosis)
·
Drugs
·
EtOH
·
Potassium
·
Inflammatory
·
Endocrine
I SEE A PI (MAD)
·
Inflammatory
·
Steroids, Statins and other drugs
·
Ethanol
·
Endocrine
·
AIDS
·
Potassium
·
Inherited
Many mechanisms can contribute to drug induced myopathy
|
|
|
|
Hypothyroid |
Weakness without cramps or myalgias Sluggish reflexes with delayed relaxation CK elevation can occur Rhabdomyolysis very rare |
|
Hyperthyroid |
Proximal weakness, cramps may occur but rare CK rarely rises |
|
Cushings |
Proximal muscle weakness with atrophy CK normal |
|
Hypokalaemia |
Proximal weakness Myalgias rare Acute or chronic CK normal or slight elevation |
|
Critical illness myopathy (usually after steroid use) |
Flaccid quadriparesis CK elevated in 50% |
|
Polymyositis |
Proximal weakness Mild to moderate myalgias in up to 50% Atrophy late in disease CK elevated in 95% LD in 90% AST/ALT in 85% |
|
Statin induced |
Myalgias common CK elevation common Rhabdomyolysis rare unless co-existing condition or other drugs
co-administered |
|
|
|
|
|
|
·
Present at birth.
·
Progress little or not at all.
·
Specific morphological abnormalities visible on
muscle biopsy.
·
Myotonia congenital (floppy infant)
·
Proximal weakness lower limbs >upper limbs
·
Occasional extraoccular
and facial involvement
·
Face and head narrow and high (dolichocephaly)
·
Often co-existent deformities pectus excavatum, scoliosus, hip dysplasia, pes cavus,
pes planus, clubfoot.
·
Reflexes normal or diminished
·
Cardiomyopathy rare
·
Reduced life expectancy is the rule
·
Occaional mental
retardation
·
CK usually normal or mild elevation
·
EMG myopathic
·
Muscle biopsy usually diagnostic with specific
features.
·
Central core disease
·
Autosomal recessive
Clinical features
Infant onset
·
Floppy infants
·
Enlargement of
o
Liver
o
Heart
o
Tongue
·
Respiratory insufficiency
·
Dysphagia
·
Life expectancy of less than 2yrs
Adult onset
·
Progressive proximal weakness
·
Respiratory insufficiency
·
Can present similarly to limb girdle or scapuloperoneal muscular dystrophy
Investigations
·
CK mildly elevated
·
EMG myopathic, CRDs
·
Lactate rises with ischaemia
test
·
Muscle biopsy
o
Glycogen laden vacuoles and lysosomes
Three types of muscle issues with statins:
· Myalgia
· Rhabdomyolysis
· Immune mediated necrotizing myopathy
Myalgia
· Many meta-analysis do not suggest a significant increase, however many poorly conducted studies
· Well conducted STOMP study
o 9% of patients had myalgia, none had impaired strength or exercise function
o ~20% of all patients had a minor elevation in CK
o None had elevation >10x ULN
o CK and myalgia do not always go together
o Myalgia with statins tended to be lower limbs proximal and calves. Myalgia on placebo more generalised.
o
· If >5x ULN consider ceasing to see if CK returns to normal (if not there may be another cause)
Rhabdomyolysis
· Rare exact incidence unknown
· High dose is a risk factor.
· Co-use with medication that increases statin concentration may be a risk factor (e.g. erythromycin, ciprofloxacin, azole anti-fungals, fibrates, calcium channel blockers, Ciclosporin)
· Not an absolute contra-indication to restarting statin, although probably at a lower dose.
Immune mediated Necrotizing Myopathy
· See other topic
Statins with pre-existing muscle disease
· Case reports only of worsening
· Possible worsening of myasthenia in some reports
· Possible reports in patients with mitochondrial myopathy
· Start low, record CK first and monitor regularly.
Reference: Statin related myopathies, Hilton-Jones, Practical neurology 2018.